First-in-human phase I study of a novel oral Wee1 inhibitor (Debio 0123) in combination with carboplatin in patients with advanced solid tumours

H. Gelderblom; J. A. Gietema; I. M. E. Desar; N. M. Ajmone; M. Jalving; J. R. Kroep; V. Nicolas; A. Vaslin; K. Tobal; D. Purcea; S. F. van Haren; L. Damstrup

doi:10.1016/j.annonc.2020.08.715

First-in-human phase I study of a novel oral Wee1 inhibitor (Debio 0123) in combination with carboplatin in patients with advanced solid tumours

H. Gelderblom, J. A. Gietema, I. M. E. Desar, N. M. Ajmone, M. Jalving, J. R. Kroep, V. Nicolas, A. Vaslin, K. Tobal, D. Purcea, S. F. van Haren, L. Damstrup

Research output: Contribution to journal › Meeting Abstract › Academic

Original language	English
Pages (from-to)	S501-S502
Number of pages	2
Journal	Annals of Oncology
Volume	31
DOIs	https://doi.org/10.1016/j.annonc.2020.08.715
Publication status	Published - Sep-2020
Event	ESMO Virtual Congress - Duration: 19-Sep-2020 → 18-Oct-2020

Access to Document

10.1016/j.annonc.2020.08.715

Cite this

Gelderblom, H., Gietema, J. A., Desar, I. M. E., Ajmone, N. M., Jalving, M., Kroep, J. R., Nicolas, V., Vaslin, A., Tobal, K., Purcea, D., van Haren, S. F., & Damstrup, L. (2020). First-in-human phase I study of a novel oral Wee1 inhibitor (Debio 0123) in combination with carboplatin in patients with advanced solid tumours. Annals of Oncology, 31, S501-S502. https://doi.org/10.1016/j.annonc.2020.08.715

Gelderblom, H. ; Gietema, J. A. ; Desar, I. M. E. ; Ajmone, N. M. ; Jalving, M. ; Kroep, J. R. ; Nicolas, V. ; Vaslin, A. ; Tobal, K. ; Purcea, D. ; van Haren, S. F. ; Damstrup, L. / First-in-human phase I study of a novel oral Wee1 inhibitor (Debio 0123) in combination with carboplatin in patients with advanced solid tumours. In: Annals of Oncology. 2020 ; Vol. 31. pp. S501-S502.

@article{1b92c1666f8c49d7b4d15548c239e24e,

title = "First-in-human phase I study of a novel oral Wee1 inhibitor (Debio 0123) in combination with carboplatin in patients with advanced solid tumours",

author = "H. Gelderblom and Gietema, {J. A.} and Desar, {I. M. E.} and Ajmone, {N. M.} and M. Jalving and Kroep, {J. R.} and V. Nicolas and A. Vaslin and K. Tobal and D. Purcea and {van Haren}, {S. F.} and L. Damstrup",

year = "2020",

month = sep,

doi = "10.1016/j.annonc.2020.08.715",

language = "English",

volume = "31",

pages = "S501--S502",

journal = "Annals of Oncology",

issn = "0923-7534",

publisher = "Oxford University Press",

note = "ESMO Virtual Congress ; Conference date: 19-09-2020 Through 18-10-2020",

}

Gelderblom, H, Gietema, JA, Desar, IME, Ajmone, NM, Jalving, M, Kroep, JR, Nicolas, V, Vaslin, A, Tobal, K, Purcea, D, van Haren, SF & Damstrup, L 2020, 'First-in-human phase I study of a novel oral Wee1 inhibitor (Debio 0123) in combination with carboplatin in patients with advanced solid tumours', Annals of Oncology, vol. 31, pp. S501-S502. https://doi.org/10.1016/j.annonc.2020.08.715

First-in-human phase I study of a novel oral Wee1 inhibitor (Debio 0123) in combination with carboplatin in patients with advanced solid tumours. / Gelderblom, H.; Gietema, J. A.; Desar, I. M. E.; Ajmone, N. M.; Jalving, M.; Kroep, J. R.; Nicolas, V.; Vaslin, A.; Tobal, K.; Purcea, D.; van Haren, S. F.; Damstrup, L.

In: Annals of Oncology, Vol. 31, 09.2020, p. S501-S502.

Research output: Contribution to journal › Meeting Abstract › Academic

TY - JOUR

T1 - First-in-human phase I study of a novel oral Wee1 inhibitor (Debio 0123) in combination with carboplatin in patients with advanced solid tumours

AU - Gelderblom, H.

AU - Gietema, J. A.

AU - Desar, I. M. E.

AU - Ajmone, N. M.

AU - Jalving, M.

AU - Kroep, J. R.

AU - Nicolas, V.

AU - Vaslin, A.

AU - Tobal, K.

AU - Purcea, D.

AU - van Haren, S. F.

AU - Damstrup, L.

PY - 2020/9

Y1 - 2020/9

U2 - 10.1016/j.annonc.2020.08.715

DO - 10.1016/j.annonc.2020.08.715

M3 - Meeting Abstract

VL - 31

SP - S501-S502

JO - Annals of Oncology

JF - Annals of Oncology

SN - 0923-7534

T2 - ESMO Virtual Congress

Y2 - 19 September 2020 through 18 October 2020

ER -